FT : Moderna’s Noubar Afeyan on the race to create a Covid vaccine Moderna’s Noubar Afeyan on the race to create a Covid vaccine The chair of the $60bn US biopharma group explains how his approach to combining science with entrepreneurship led to the company’s creation Download Moderna_s_Noubar_Afeyan_on_the_race_to_create_a_Covid_vaccine___Financial_Times.pdf